Seeking Alpha

  Sevion Therapeutics, Inc. - OTCQB

10/21/2014, 11:13 PM ET
52wk high:  
52wk low:  
PE (ttm):  
Div Rate:  
Market Cap:  
SVON vs. ETF Alternatives
Company Description
The company's platform technology is based on the discovery that eIF5A (Factor 5A), a gene that is highly conserved from plants to people, has the ability to regulate programmed cell death, also known as apoptosis, and cell survival by controlling the expression of pro-apoptotic and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States